Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Sorrento Therape (SRNE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sorrento Therape's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1.440 -0.010    -0.69%
16:00:04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US83587F2020 
CUSIP:  83587F202
  • Volume: 5,251,231
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.400 - 1.490
Sorrento Therape 1.440 -0.010 -0.69%

SRNE Analysis

 
This page features the latest analysis and reports for the Sorrento Therape stock.
Zacks Investment Research
Company News For Mar 23, 2020 By Zacks Investment Research - Mar 22, 2020 1

Shares of Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) surged more than 100% after the companyreported that the FDA granted emergency expanded access for INOpulse to treat coronavirus.Shares of...

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

SRNE Comments

Write your thoughts about Sorrento Therape
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Matt Skinner
Matt Skinner May 02, 2022 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This compny will reverse split before you see 3 agian just sell.
Reply
0 3
Report
mark slaughter
mark slaughter May 02, 2022 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You must be shorting the stock
Reply
1 0
Report
DPP TCR
DPP TCR Apr 29, 2022 11:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Gents I've gotta level with you, as Crim Jamer mentioned on 18th April 2022, the possibility of SRNE going below $1 seems very much likely...If I had the cash I would definitely buy more and average but the fact is for this to come back to a solid $10 and above range is going to be a waiting period of at least 5 years..hoping the time period is less but things look really f88ked up, pretty much operators manipulating the stock to have us sell off and they can reap this really cheap and then enjoy selling it out at anywhere between $12 - $18, while we look on as twits. Those who can average they should, those who can't lets wait it out.
Reply
3 0
Report
mark slaughter
mark slaughter Apr 29, 2022 11:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What are you??… a human crystal ball!?!?… 5 years???🤔… you think its gonna be 5 years before anything is approved??
Reply
0 0
Report
Sudipto Adhikari
Sudipto Adhikari Apr 21, 2022 7:53AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This needs to have M&A !!!!!!!!!!!
Reply
1 0
Report
Edwin Henriquez
Edwin Henriquez Apr 18, 2022 2:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
really something else this company and if you notice they haven't promoted any news is like they want this stock to zinc to a dollar level
Reply
0 0
Report
Sudipto Adhikari
Sudipto Adhikari Apr 18, 2022 2:13PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
THIS IS SOMETHING WHERE THE WIN - WIN RATIO IS HOVERING AROUND 50 - 50.
Reply
1 0
Report
Sudipto Adhikari
Sudipto Adhikari Apr 18, 2022 2:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
SHORTS % 53 MILLION
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Apr 12, 2022 5:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Other large investors have also modified their holdings of the company. Arizona State Retirement System increased its stake in shares of Sorrento Therapeutics by 2.7% during the third quarter. Arizona State Retirement System now owns 74,376 shares of the biopharmaceutical company’s stock worth $567,000 after buying an additional 1,986 shares during the period. Crescent Grove Advisors LLC lifted its holdings in shares of Sorrento Therapeutics by 10.0% during the third quarter. Crescent Grove Advisors LLC now owns 22,000 shares of the biopharmaceutical company’s stock worth $168,000 after purchasing an additional 2,000 shares during the period. AE Wealth Management LLC lifted its holdings in shares of Sorrento Therapeutics by 17.0% during the third quarter. AE Wealth Management LLC now owns 14,661 shares of the biopharmaceutical company’s stock worth $112,000 after purchasing an additional 2,126 shares during the period. Newbridge Financial Services Group Inc. lifted its holdings in shar
Reply
1 0
Report
DPP TCR
DPP TCR Apr 12, 2022 5:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wow thats a lot of pick up fo SRNE, so a boom is coming in soon, just need to see when.
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Apr 12, 2022 5:02PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hey be alert I have a feeling this next Monday will be at 5 levels lots of shorters closing on Friday so Monday we should moon hopefully brother
Reply
0 0
Report
Edwin Henriquez
Edwin Henriquez Apr 12, 2022 10:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lets see it looks like this company has the best pipe line and good news we just need to ready for a short squeeze on Thursday or Friday seen most contracts expired on Friday it should fly
Reply
1 0
Report
Show previous replies (2)
DPP TCR
DPP TCR Apr 12, 2022 10:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
True that, just need to be able to hold on as long as we can. So for now we have invested and just forget.
Reply
0 0
Report
Crim Jamer
Crim Jamer Apr 12, 2022 10:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
you might need a second alert for .70c
Reply
0 0
Report
DPP TCR
DPP TCR Apr 12, 2022 10:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thats going to be the worst case scenario Crim, if it reaches 70 cents then uffff we're f*ked
Reply
0 0
Report
DPP TCR
DPP TCR Apr 12, 2022 10:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Really hope it doesn't buddy!
Reply
0 0
Report
Crim Jamer
Crim Jamer Apr 12, 2022 10:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i'm also holding the bag from 8 *****analyst price target was like $26 last february? LOL.
Reply
0 0
Report
DPP TCR
DPP TCR Apr 11, 2022 11:17AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1.917 and going lower, thats it, yeesh! What a bummer!
Reply
0 0
Report
Sudipto Adhikari
Sudipto Adhikari Apr 11, 2022 6:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any News on BIG PHARMAS are looking for SORRENTO !!!
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email